Isomorphic Labs Raises $5 Billion Months After $2.1 Billion Round
Alphabet-backed Isomorphic Labs raised $5 billion in a Series C round co-led by Greenoaks and Sequoia Capital, about six months after its $2.1 billion Series B. Alphabet, Andreessen Horowitz and other investors also participated. The Google DeepMind spinoff will use the funding to develop its AI drug-design engine, IsoDDE, advance preclinical programs in oncology and immunology, and build the capabilities needed to move its first candidates into human trials. Isomorphic reports positive preclinical results and has partnerships with major drugmakers, but has not disclosed detailed data; its candidates’ performance in human testing remains unproven.






